Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.
Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived endotoxin plays an essential role in the pathophysiological development and progression of NAFLD. By using rat models of choline...
Main Authors: | Hitoshi Endo, Maki Niioka, Noriko Kobayashi, Mamoru Tanaka, Tetsu Watanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3656030?pdf=render |
Similar Items
-
Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023) -
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
by: Alejandra Mijangos-Trejo, et al.
Published: (2023-10-01) -
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
by: Tian-Yi Ren, et al.
Published: (2021-01-01) -
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
by: Rui Xue, et al.
Published: (2021-10-01) -
Induction of peroxisomes by butyrate-producing probiotics.
by: Huachun Weng, et al.
Published: (2015-01-01)